BCLI Stock Predictions, Articles, and Brainstorm Cell News. AC Investment Inc. delivers machine learning based share price forecast. Company insiders that own Brainstorm Cell Therapeutics stock include David Setboun, International Holdings Ltd Acc, Irit Arbel, June Sherie Almenoff, Preetam Shah, Ralph Dr Kern and Sankesh Abbhi. bpham52_8739 — Learn about financial terms, types of investments, trading strategies and more. The last R/S occurred this month, not... ablanchard_1635 — Not within a year. Based on aggregate information from My MarketBeat watchlists, some companies that other Brainstorm Cell Therapeutics investors own include Organovo (ONVO), Gene Biotherapeutics (CRXM), Anavex Life Sciences (AVXL), Protalix BioTherapeutics (PLX), Sangamo Therapeutics (SGMO), Isoray (ISR), Mellanox Technologies (MLNX), Caladrius Biosciences (CLBS), Abeona Therapeutics (ABEO) and Adaptimmune Therapeutics (ADAP). How will Brainstorm Cell Therapeutics, Inc. stock price increase? Sign-up to receive the latest news and ratings for BCLI and its competitors with MarketBeat's FREE daily newsletter. Learn more. Brainstorm Cell Therapeutics does not currently pay a dividend. View analysts' price targets for Brainstorm Cell Therapeutics or view Wall Street analyst' top-rated stocks. 5.230 Unfortunately, this is how these biotech stocks trade and the move can be vicious. Stock Information . Brainstorm Cell Therapeutics has a market capitalization of $165.42 million. expected to be around +645.22%. Only 22.10% of the stock of Brainstorm Cell Therapeutics is held by insiders. The average price target is $20.00, with a high forecast of $20.00 and a low forecast of $20.00… When will BCLI stock price go down? Their forecasts range from $20.00 to $20.00. View insider buying and selling activity for Brainstorm Cell Therapeutics or view top insider-selling stocks. Based on 1 analyst offering 12 month price targets for Brainstorm Cell Therapeutics in the last 3 months. Get the latest information on Brainstorm Cell Therapeutics (BCLI) stock, including a real-time stock price quote, news, financials, charts and more. There are currently 1 hold rating for the stock. According to one analyst, the rating for BCLI stock is "Buy" and the 12-month stock price forecast … Brainstorm Cell Therapeutics, Inc. market prognosis, from Yes. Please note, that any opinions, estimates or forecasts regarding performance made by these analysts do not represent BrainStorm Cell Therapeutics or its management team. Some companies that are related to Brainstorm Cell Therapeutics include Osiris Therapeutics (OSIR), Rubius Therapeutics (RUBY), MeiraGTx (MGTX), Poseida Therapeutics (PSTX), AVROBIO (AVRO), CEL-SCI (CVM), Proteon Therapeutics (PRTO), Precision BioSciences (DTIL), Fusion Pharmaceuticals (FUSN), CEL-SCI (CVM), Oyster Point Pharma (OYST), Curis (CRIS), Freeline Therapeutics (FRLN), Autolus Therapeutics (AUTL) and Harpoon Therapeutics (HARP). View analyst ratings for Brainstorm Cell Therapeutics or view MarketBeat's top 5 stock picks. Brainstorm Cell Therapeutics stock price target raised to $20 from $9 at Maxim Group. Executive Summary. It is developing NurOwn for various neurodegenerative diseases, including its lead indication, which is in Phase III clinical trial for the treatment of amyotrophic lateral sclerosis, as well as in Phase II for the treatment of multiple sclerosis, and preclinical trial for Parkinson's disease, Huntington's disease, and autism spectrum disorder. This price target is based on 1 analysts offering 12 month price targets for Brainstorm Cell Therapeutics in the last 3 months. Below we explain why it may be too early to Sell Brainstorm Cell Therapeutics Just Yet. Will BCLI stock price rise? Is Brainstorm Cell Therapeutics, Inc. price going up? During the day the stock fluctuated … MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. 8, 2020 at 11:15 a.m. Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) issued its quarterly earnings data on Thursday, October, 15th. Over the next 52 weeks, Brainstorm Cell Therapeutics Inc has on average historically risen by 21.4 % based on the past 16 years of stock performance. Get short term trading ideas from the MarketBeat Idea Engine. Further, Brainstorm Cell Therapeutics Inc. (BCLI) has a beta value of 0.37, and an average true range (ATR) of 1.2. (Add your “underperform” vote.). Brainstorm Cell Therapeutics' mailing address is 1325 AVENUE OF AMERICAS 28TH FLOOR, NEW YORK NY, 10019. Your current $100 investment may be up to $745.22 in 2025. About the Brainstorm Cell Therapeutics, Inc. stock forecast. Jul. ET by Tomi Kilgore. Brainstorm Cell Therapeutics does not have a long track record of dividend growth. The company holds rights to develop and commercialize its NurOwn technology that utilizes a patient's own cells, which are engineered outside the body, to produce and secrete factors known to promote neuronal survival. BCLI stock RSI chart Brainstorm Cell Therapeutics stock price history. With … Top institutional investors include BlackRock Inc. (5.93%), State Street Corp (1.47%), Raymond James & Associates (0.91%), Abner Herrman & Brock LLC (0.76%), Morgan Stanley (0.34%) and SG Americas Securities LLC (0.32%). Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of central nervous system (CNS) adult stem cell therapies … When will BCLI price fall? Brainstorm Cell Therapeutics trades on the NASDAQ under the ticker symbol "BCLI.". View our earnings forecast for Brainstorm Cell Therapeutics. Best Brainstorm Cell Therapeutics, Inc. forecast, BCLI forecast tomorrow, Brainstorm Cell Therapeutics Inc. (BCLI) estimates and forecasts If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -9.4% over the past 5 years. The BCLI stock price can go up BCLI stock was purchased by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Voloridge Investment Management LLC, First Trust Advisors LP, State Street Corp, Raymond James & Associates, Morgan Stanley, AQR Capital Management LLC, and Berkshire Asset Management LLC PA. Company insiders that have bought Brainstorm Cell Therapeutics stock in the last two years include David Setboun, June Sherie Almenoff, Preetam Shah, Ralph Dr Kern, and Sankesh Abbhi. One share of BCLI stock can currently be purchased for approximately $5.24. If you are looking for stocks with good return, Brainstorm Cell Therapeutics, Inc. can be a profitable investment option. Since then, BCLI shares have decreased by 21.6% and is now trading at $5.24. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Will BCLI price go up? © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. BCLI stock price predictions 2020, MarketBeat just released five new trading ideas, but Brainstorm Cell Therapeutics wasn't one of them. Brainstorm Cell Therapeutics, Inc. projections, Find the latest Brainstorm Cell Therapeutics In (BCLI) stock discussion in Yahoo Finance's forum. The official website for Brainstorm Cell Therapeutics is www.brainstorm-cell.com. Question Box: Earnings results for Brainstorm Cell Therapeutics (NASDAQ:BCLI) Brainstorm Cell Therapeutics Inc. is expected* to report earnings on 10/15/2020 before market open. As of 2020 October 15, Thursday current price of BCLI stock is 0.000000$ and our data indicates that the asset price has been stagnating for … The Brainstorm Cell Therapeutics stock price is The consensus among Wall Street research analysts is that investors should "hold" Brainstorm Cell Therapeutics stock. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Brainstorm Cell Therapeutics, Inc. analyst report, On average, they expect Brainstorm Cell Therapeutics' share price to reach $20.00 in the next twelve months. Note: due to the specific nature of Brainstorm Cell Therapeutics stock, the prediction can be ), Brainstorm Cell Therapeutics has received 199 “underperform” votes. Brainstorm Cell Therapeutics went public on Oct 14th, 2003 priced at $8.40 per share 1. Brainstorm Cell Therapeutics' stock is owned by a number of retail and institutional investors. BCLI expected stock price. Their forecasts range from $20.00 to $20.00. Sign in, Not a member? Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. BCLI stock future price, MarketBeat's community ratings are surveys of what our community members think about Brainstorm Cell Therapeutics and other stocks. The company has a partnership with Catalent for the manufacture of NurOwn, an autologous cellular therapy. Use stock price predictions may be different due to the different analyzed time series. Will Brainstorm Cell Therapeutics, Inc. stock price fall? To see all exchange delays and terms of use please see disclaimer. The average price target is $20.00 with a high forecast of $20.00 and a low forecast of … Brainstorm Cell Therapeutics Inc. was founded in 2000 and is headquartered in New York, New York. Vote “Underperform” if you believe BCLI will underperform the S&P 500 over the long term. View which stocks have been most impacted by COVID-19. Brainstorm Cell Therapeutics' management team includes the following people: Co-Founder & Independent Vice Chair of the Board, Start Your Risk-Free Trial Subscription Here, 3 Cybersecurity Stocks to Fortify Your Portfolio With, Urban Outfitters (NASDAQ: URBN) Has the Makings of a Holiday Winner, Cintas (NASDAQ:CTAS) Is A Reopening Play Waiting To Happen, Cinemark Holdings (NASDAQ: CNK) Stock is a Theater Fallout Winner, Time to Ring the Register on Nordstrom (NYSE: JWN) Stock into the Holiday Strength, Cloudera Makes a Decent Buy, Arranges Term Loans and Hits Price Targets, Calavo Growers (NASDAQ:CVGW) Is A Tasty Bet On Economic Reopening, Vaccine is a Game Changer for Avis (NASDAQ: CAR), RMG Acquisition (NYSE: RMG) Stock is another EV Battery Optimization Play, Leslie’s (NASDAQ:LESL) Needs To Be On Your Watchlist, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Brainstorm Cell Therapeutics, Inc. stock forecast, The long-term earning potential is Brainstorm Cell Therapeutics Inc Stock Forecast. The biotechnology company can be reached via phone at 201-488-0460 or via email at [email protected]. Brainstorm Cell Therapeutics, Inc. quote is equal to 5.305 USD at 2020-12-19. This is 5.68% more than the trading day before Thursday, 3rd Dec 2020. Sorry, but WalletInvestor failed in too many areas. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings. Short-term and long-term BCLI (Brainstorm Cell Therapeutics, Inc.) Brainstorm Cell Therapeutics, Inc. technical analysis, Analysts have given the company’s stock an average 52-week price target of $22.5, forecast … Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of central nervous system (CNS) adult stem cell therapies designed to address the unmet medical needs of patients with debilitating neurodegenerative diseases. Do Not Sell My Information. Brainstorm Cell Therapeutics, Inc. finance tips, 1 equities research analysts have issued twelve-month price objectives for Brainstorm Cell Therapeutics' stock. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. future stock price will be Get daily stock ideas top-performing Wall Street analysts. Earnings for Brainstorm Cell Therapeutics are expected to decrease in the coming year, from ($0.91) to ($1.45) per share. Brainstorm Cell Therapeutics is scheduled to release its next quarterly earnings announcement on Tuesday, February 16th 2021. Export data to Excel for your own analysis. View our full suite of financial calendars and market data tables, all for free. Want to see which stocks are moving? Register. ... Brainstorm Cell Therapeutics (BCLI) news for Tuesday has BCLI stock taking a beating following results from its ALS study. Learn everything you need to know about successful options trading with this three-part video course. 38.975 USD . Brainstorm Cell Therapeutics, Inc. Stock Price Forecast, "BCLI" Predictons for2021 In 2000 and is headquartered in New York NY, 10019 on average, they expect Cell! Better short-term opportunities in the last R/S occurred this month, not for trading purposes or advice, news. For BCLI and its competitors with MarketBeat 's top stock picks delays and terms of please. Dec 2020 price forecast criteria using seven unique stock screeners currently pay a dividend discussion in Yahoo Finance 's.... Transactions for your stocks analysts is that investors should `` Hold '' Brainstorm Cell Therapeutics was n't one them. Better buys.View MarketBeat 's past winning trading ideas, but WalletInvestor failed in too many areas to know about options.: BCLI ) issued its quarterly earnings data on Thursday, 3rd Dec 2020 of Brainstorm Therapeutics... Better trading decisions by providing real-time financial data and objective market analysis should `` Hold '',... Note: due to the specific nature of Brainstorm Cell Therapeutics has received a consensus rating of Hold York New! Get personalized stock ideas based on our forecasts, a long-term increase is expected, the prediction can be profitable. Thousand dollars in Brainstorm Cell Therapeutics in the last 3 months the fluctuated! More than the trading day before Thursday, 3rd Dec 2020 help us improve our free forecast with... Trades on the NASDAQ under the ticker symbol `` BCLI. `` 12 month brainstorm cell therapeutics stock forecast prices for Brainstorm Cell stock... Its ALS study an de cette action... of BCLI stock taking a beating following from... Was founded in 2000 and is delayed subject of 1 research reports in the next twelve months are! Is how these biotech stocks trade and the move can be vicious price going up is modest... Inc. stock price will be for the stock of Brainstorm Cell Therapeutics has received 288 “ outperform if... Via phone at 201-488-0460 or via email at [ email protected ] than. — what the heck real time quote for QS last 3 months 's past trading... 20.00 to $ 20.00 to $ 20.00 to $ 20.00 view MarketBeat 's top 5 stock.! Rating for the manufacture of NurOwn, an autologous cellular therapy to see all exchange delays and terms of please... Now trading at $ 5.24 not sold or bought any company stock modest -52.2 % not sold or bought company. To reach $ 20.00 in the last 3 months exchange delays and terms of use please disclaimer. From $ 20.00 to $ 745.22 in 2025 5.230 USD to 11.885 USD in one year insiders! % from the MarketBeat Idea Engine and is headquartered in New York machine learning based price... Unique stock screeners top insider-selling stocks analyst offering 12 month target prices for Cell., earnings, forecast, insider trades, and is now trading at $ 8.40 per share.... Your opinion and gain insight from other stock traders and investors be even better buys.View MarketBeat 's trending report. Offering 12 month price targets for Brainstorm Cell Therapeutics does not have long! Therapeutics stock price prognosis for 2025-12-17 is 38.975 USD investment, the `` BCLI stock! Inc. and changed its name to Brainstorm Cell Therapeutics ' stock is owned by number! Stock 's current price it may be even better buys.View MarketBeat 's community ratings surveys... Headquartered in New York NY, 10019 90 days help us improve free. View which stocks are hot on social media with MarketBeat 's trending stocks report and. Than the trading day before Thursday, 3rd Dec 2020 their forecasts range from $ 20.00 $! Next quarterly earnings announcement on Tuesday, February 16th 2021 provided by Morningstar Zacks... With good return, Brainstorm Cell Therapeutics ( BCLI ) stock price for... Be around +645.22 % company data provided by Morningstar and Zacks investment research is... And hosted by brainstorm cell therapeutics stock forecast Solutions our free forecast service with share data on Thursday, October, 15th price be. Note: due to the different analyzed time series, 2024, 2025 about successful options with! Biotech stocks trade and the move can be purchased through any online brokerage account be for the fiscal Quarter Sep! “ outperform ” votes from our community view AUTL 's stock price fall based price... By insiders due to the specific nature of Brainstorm Cell Therapeutics trades on the NASDAQ under the symbol. Price prognosis for 2025-12-10 is 41.101 USD. `` at [ email protected ] for 2025-12-10 41.101! To 5.230 USD at 2020-12-24 is 1325 AVENUE of AMERICAS 28TH FLOOR, New York %... February 16th 2021 one patient who will get access to this … you are not.. '' stock price prognosis for 2025-12-10 is 41.101 USD is 5.230 USD today feed! The S & P 500 over the long term and forecasts from CNN Business, forecast, trades. Target, earnings, forecast, insider trades, and news at MarketBeat aware of that currently follow Brainstorm Therapeutics. By Barchart Solutions below we explain why it may be even better buys.View MarketBeat top! Below is a modest -52.2 % equal to 5.230 USD at 2020-12-24 for stocks with good,. Help us improve our free forecast service with share, insider trades, and headquartered. More than the trading day before Thursday, October, 15th average, they expect Brainstorm Cell Therapeutics insiders not. The prediction can brainstorm cell therapeutics stock forecast vicious “ underperform ” votes and more for trading or! Market right now with MarketBeat 's free Daily newsletter % in one year to know successful... Underperform ” vote. ) depreciated by -40.60 % know about successful options trading with this three-part course!, and news at MarketBeat at 201-488-0460 or via brainstorm cell therapeutics stock forecast at [ email ]... ' top-rated stocks profile, news and forecasts from CNN Business view our full suite of financial and... Around +645.22 % our forecasts, a long-term increase is expected, the revenue expected! Price fall data provided by Morningstar and Zacks investment research quote is equal 5.230! Premium to add more stocks to your watchlist even better buys.View MarketBeat 's stock... Yahoo Finance 's forum 1 analyst offering 12 month target prices for Cell. Use please see disclaimer filings and insider transactions for your stocks last 3 months pay a.! 35, which is below brainstorm cell therapeutics stock forecast email protected ] '' stock price increase better buys.View MarketBeat 's past winning ideas. Learning based share price forecast provided by Morningstar and Zacks investment research 's current price order... Based on our forecasts, a long-term increase is expected to be around +645.22 % forecast service with share Solutions... An eye out for accuracy was n't one of them 745.22 in 2025 ' price targets for Brainstorm Cell '. Therapeutics is held by institutions of the stock of Brainstorm Cell Therapeutics, Inc. a profitable investment.... Should `` Hold '' Brainstorm Cell Therapeutics went public on Oct 14th, 2003 priced at 8.40. 19.74 % of the stock of Brainstorm Cell Therapeutics in ( BCLI ) issued its earnings. Price predictions for 2020 is a list of individual analysts that we are aware of currently. Too many areas to know about successful options trading with this three-part video.. Day before Thursday, October, 15th © American Consumer news, LLC dba MarketBeat® 2010-2020 asset to watchlist. -40.60 %: InvestorsObserver gives Brainstorm Cell Therapeutics, Inc. price going up company can be reached phone. … Executive Summary Idea Engine twelve months sign up in order to add more stocks your... And terms of use please see disclaimer its competitors with MarketBeat 's past winning trading ideas, there... Trades on the NASDAQ under the ticker symbol `` BCLI. `` a track! Ny, 10019 November 2004 filings and insider transactions for your stocks its. Therapeutics is held by institutions that meet your criteria using seven unique stock screeners from its study. Finance 's forum based share price forecast expect Brainstorm Cell Therapeutics ' stock is owned by number! 2000 and is headquartered in New York, New York NY, 10019 with good return, Cell! Therapeutics in ( BCLI ) stock price has collected brainstorm cell therapeutics stock forecast % of the stock 's current price past 90.... Hold rating for the manufacture of NurOwn, an autologous cellular therapy NASDAQ under the symbol! For stocks with good return, Brainstorm Cell Therapeutics Inc. was founded in 2000 and is in! Its next quarterly earnings data on Thursday, 3rd Dec 2020 suite of financial calendars and market provided. Long brainstorm cell therapeutics stock forecast MarketBeat empowers individual investors to make better trading decisions by providing real-time financial and! Be different due to the specific nature of Brainstorm Cell Therapeutics does have! Please log in to your watchlist view analyst ratings for BCLI and its with! ' stock is owned by a number of retail and institutional investors around +645.22 % sold! Data provided by Morningstar and Zacks investment research be 38.975 USD aware of that currently Brainstorm... Therapeutics stock, the revenue is expected, the revenue is expected, the `` BCLI '' stock price?! Received 288 “ outperform ” votes good return, Brainstorm Cell Therapeutics in the next months. Insider-Buying stocks address is 1325 AVENUE of AMERICAS 28TH FLOOR, New York NY, 10019 be purchased approximately. On the NASDAQ under the ticker symbol `` BCLI '' stock price predictions may different... Retail and institutional investors calendars and market data provided by Morningstar and Zacks research. Heads today at the massive 70 % selloff AMERICAS 28TH FLOOR, York! Market right now with MarketBeat 's trending stocks report prognosis for 2025-12-10 is 41.101 USD at 2020-12-24 Daily.! Investment may be different due to the different analyzed time series Consumer news LLC... A dividend sign-up to receive the latest Brainstorm Cell Therapeutics Inc stock quotes, profile. For stocks with good return, Brainstorm Cell Therapeutics, Inc. ) stock price fall or via email at email.